07 - 09 September
The healthcare market is one of the fastest growing industries worldwide. Continuous research in this industry supports the treatment of many patients. However, efficient therapy can only be guaranteed if a clear diagnosis has been made previously. So far, biobanks often cannot cover the needs for suitable research material due to the versatility of the samples. We counteract this deficit by producing and placing samples on the market. They are used for finding new biomarkers for the development of new tests and for quality controls. Due to the diversity of materials procurement is very complex. By digitising of the procedure, we want to identify new ways of efficient care and familiarise you with the legal framework.
So far no information materials were provided for this event. Please contact the organizer directly for further information.
Managing Director, in.vent Diagnostica GmbH
Go to profile
21 May. 2019 - 23 May. 2019
The BIOTECHNICA FORUM is the ideal platform for scientific exchange and the discussion of topical issues and areas of ...
What could a fully digitized and networked laboratory of the future look like? smartLAB has been answering this question at ...
21 May. 2019, 10:00 AM - 10:15 AM
Dr. Kathrin Brenker
- Opto Biolabs GbR, Freiburg